FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine

Retrieved on: 2024-06-04 13:35:12

Tags for this article:

Click the tags to see associated articles and topics

FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine. View article details on hiswai:

Excerpt

The KP.2 subvariant is now dominant in the U.S., FDA staff says in a briefing document.

Article found on: www.medpagetoday.com